Skip to main content
Journal cover image

Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.

Publication ,  Journal Article
Machado, MV; Michelotti, GA; Pereira, TA; Xie, G; Premont, R; Cortez-Pinto, H; Diehl, AM
Published in: J Hepatol
October 2015

BACKGROUND & AIMS: Mechanisms that regulate regeneration of injured livers are complex. YAP, a stem cell associated factor, controls liver growth in healthy adult mice. Increasing nuclear localization of YAP triggers accumulation of reactive-appearing ductular cells (YAP+RDC) with liver progenitor capabilities. The significance of YAP activation, and mechanisms involved, are unknown in diseased livers. We evaluated the hypothesis that YAP is more activated in injured livers that are scarring than in those that are regenerating effectively. METHODS: Immunohistochemistry and qRT-PCR analysis were used to localize and quantify changes in YAP and RDC in 52 patients with non-alcoholic fatty liver disease (NAFLD) and two mouse models of diet-induced non-alcoholic steatohepatitis (NASH). Results were correlated with liver disease severity, metabolic risk factors, and factors proven to control NAFLD progression. RESULTS: YAP increased in NAFLD where it mainly localized in nuclei of RDC that expressed progenitor markers. Accumulation of YAP+RDC paralleled the severity of hepatocyte injury and accumulation of Sonic hedgehog, but not steatosis or metabolic risk factors. YAP+RDC expressed osteopontin, a Shh-regulated fibrogenic factor. Myofibroblast accumulation, fibrosis, and numbers of YAP+RDC strongly correlated. In murine NASH models, atrophic fibrotic livers contained significantly more YAP+RDC than livers with less severe NASH. CONCLUSION: YAP+RDC promote scarring, rather than effective regeneration, during NASH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Hepatol

DOI

EISSN

1600-0641

Publication Date

October 2015

Volume

63

Issue

4

Start / End Page

962 / 970

Location

Netherlands

Related Subject Headings

  • YAP-Signaling Proteins
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Messenger
  • Phosphoproteins
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Liver Cirrhosis, Experimental
  • Immunohistochemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Machado, M. V., Michelotti, G. A., Pereira, T. A., Xie, G., Premont, R., Cortez-Pinto, H., & Diehl, A. M. (2015). Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol, 63(4), 962–970. https://doi.org/10.1016/j.jhep.2015.05.031
Machado, Mariana Verdelho, Gregory Alexander Michelotti, Thiago Almeida Pereira, Guanhua Xie, Richard Premont, Helena Cortez-Pinto, and Anna Mae Diehl. “Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.J Hepatol 63, no. 4 (October 2015): 962–70. https://doi.org/10.1016/j.jhep.2015.05.031.
Machado MV, Michelotti GA, Pereira TA, Xie G, Premont R, Cortez-Pinto H, et al. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol. 2015 Oct;63(4):962–70.
Machado, Mariana Verdelho, et al. “Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.J Hepatol, vol. 63, no. 4, Oct. 2015, pp. 962–70. Pubmed, doi:10.1016/j.jhep.2015.05.031.
Machado MV, Michelotti GA, Pereira TA, Xie G, Premont R, Cortez-Pinto H, Diehl AM. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol. 2015 Oct;63(4):962–970.
Journal cover image

Published In

J Hepatol

DOI

EISSN

1600-0641

Publication Date

October 2015

Volume

63

Issue

4

Start / End Page

962 / 970

Location

Netherlands

Related Subject Headings

  • YAP-Signaling Proteins
  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA, Messenger
  • Phosphoproteins
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Liver Cirrhosis, Experimental
  • Immunohistochemistry